Joel Greenblatt's AMGN Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 24,836 shares of Amgen Inc. (AMGN) worth $8.13 M, representing 0.03% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 49 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in AMGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2015, adding 298,741 shares. Largest reduction occurred in Q3 2016, reducing 216,729 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Amgen (AMGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amgen (AMGN) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +4,342 | Add 21.19% | 24,836 | $327.31 |
| Q3 2025 | -2,809 | Reduce 12.05% | 20,494 | $282.20 |
| Q2 2025 | -2,259 | Reduce 8.84% | 23,303 | $279.21 |
| Q1 2025 | +3,824 | Add 17.59% | 25,562 | $311.55 |
| Q4 2024 | +333 | Add 1.56% | 21,738 | $260.64 |
| Q3 2024 | -735 | Reduce 3.32% | 21,405 | $322.21 |
| Q2 2024 | -1,664 | Reduce 6.99% | 22,140 | $312.45 |
| Q1 2024 | -17,586 | Reduce 42.49% | 23,804 | $284.32 |
| Q4 2023 | +9,164 | Add 28.44% | 41,390 | $288.02 |
| Q3 2023 | -2,976 | Reduce 8.45% | 32,226 | $268.76 |
| Q2 2023 | +16,890 | Add 92.23% | 35,202 | $222.02 |
| Q1 2023 | -3,246 | Reduce 15.06% | 18,312 | $241.75 |
| Q4 2022 | +3,372 | Add 18.54% | 21,558 | $262.64 |
| Q3 2022 | -384 | Reduce 2.07% | 18,186 | $225.39 |
| Q2 2022 | +8,736 | Add 88.83% | 18,570 | $243.30 |
| Q1 2022 | +5,025 | Add 104.49% | 9,834 | $241.81 |
| Q4 2021 | +2,646 | Add 122.33% | 4,809 | $224.99 |
| Q3 2021 | +2,163 | New Buy | 2,163 | $212.67 |
| Q2 2021 | -7,917 | Sold Out | 0 | $0.00 |
| Q1 2021 | +3,876 | Add 95.92% | 7,917 | $248.83 |
| Q4 2020 | -4,155 | Reduce 50.70% | 4,041 | $229.89 |
| Q3 2020 | -2,371 | Reduce 22.44% | 8,196 | $254.15 |
| Q2 2020 | -20,579 | Reduce 66.07% | 10,567 | $235.83 |
| Q1 2020 | -106,659 | Reduce 77.40% | 31,146 | $202.72 |
| Q4 2019 | +88,088 | Add 177.18% | 137,805 | $241.07 |
| Q3 2019 | -61,788 | Reduce 55.41% | 49,717 | $193.52 |
| Q2 2019 | -91,812 | Reduce 45.16% | 111,505 | $184.28 |
| Q1 2019 | +107,258 | Add 111.66% | 203,317 | $189.98 |
| Q4 2018 | -52,844 | Reduce 35.49% | 96,059 | $194.67 |
| Q3 2018 | -5,605 | Reduce 3.63% | 148,903 | $207.29 |
| Q2 2018 | -118,847 | Reduce 43.48% | 154,508 | $184.59 |
| Q1 2018 | +59,697 | Add 27.94% | 273,355 | $170.48 |
| Q4 2017 | -24,193 | Reduce 10.17% | 213,658 | $173.90 |
| Q3 2017 | +3,567 | Add 1.52% | 237,851 | $186.45 |
| Q2 2017 | -163,060 | Reduce 41.04% | 234,284 | $172.23 |
| Q1 2017 | +85,964 | Add 27.61% | 397,344 | $164.07 |
| Q4 2016 | +42,176 | Add 15.67% | 311,380 | $146.21 |
| Q3 2016 | -216,729 | Reduce 44.60% | 269,204 | $166.81 |
| Q2 2016 | +162,528 | Add 50.26% | 485,933 | $152.15 |
| Q1 2016 | +46,654 | Add 16.86% | 323,405 | $149.93 |
| Q4 2015 | -129,355 | Reduce 31.85% | 276,751 | $162.33 |
| Q3 2015 | -53,019 | Reduce 11.55% | 406,106 | $138.32 |
| Q2 2015 | +149,991 | Add 48.52% | 459,125 | $153.52 |
| Q1 2015 | +298,741 | Add 2874.44% | 309,134 | $159.85 |
| Q4 2014 | +7,700 | Add 285.93% | 10,393 | $159.34 |
| Q3 2014 | -7,245 | Reduce 72.90% | 2,693 | $140.36 |
| Q2 2014 | +9,938 | New Buy | 9,938 | $118.33 |
| Q1 2014 | -23,170 | Sold Out | 0 | $0.00 |
| Q4 2013 | +23,170 | New Buy | 23,170 | $114.07 |
Joel Greenblatt's Amgen Investment FAQs
Joel Greenblatt first purchased Amgen Inc. (AMGN) in Q4 2013, acquiring 23,170 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Amgen Inc. (AMGN) for 49 quarters since Q4 2013.
Joel Greenblatt's largest addition to Amgen Inc. (AMGN) was in Q1 2015, adding 309,134 shares worth $49.42 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 24,836 shares of Amgen Inc. (AMGN), valued at approximately $8.13 M.
As of the Q4 2025 filing, Amgen Inc. (AMGN) represents approximately 0.03% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Amgen Inc. (AMGN) was 485,933 shares, as reported at the end of Q2 2016.